summary advice - switching from a serotonin and noradrenaline reuptake inhibitor (SNRI) to another antidepressant

Last edited 04/2023 and last reviewed 05/2023

Summary advice switching from a serotonin and noradrenaline reuptake inhibitor (SNRI) to another antidepressant

This section is based on a summary of advice from the NHS Specialist Pharmacy Service.

Reference:

Related pages:

switching antidepressant treatment

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to agomelatine in adults

switching antidepressant - switching from an SNRI (e.g. duloxetine or venlafaxine) to mirtazapine in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to moclobemide in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to monoamine oxidase inhibitors (MAOIs) in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to selective serotonin reuptake inhibitors (SNRIs) in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to trazodone in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to tricyclic antidepressants (TCAs) in adults

switching antidepressant - SNRI (e.g. duloxetine or venlafaxine) to vortioxetine in adults